Comparable stake leader
Section 32 Fund 3, LP
SEC ownership of DA32 Life Science Tech Acquisition Corp.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001863294.
Disclosed value leader
Section 32 Fund 3, LP
Comparable rows
0/6
Latest evidence
28 Jul 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Section 32 Fund 3, LP
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
28 Jul 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001863294
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of DA32 Life Science Tech Acquisition Corp. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Section 32 Fund 3, LP
Disclosed value leader
Section 32 Fund 3, LP
Comparable rows
0/6
Latest evidence
28 Jul 2023
3/4/5
Highest disclosed value: $93,600,000
6 rows are not safely comparable across share classes.
Quick read
Section 32 Fund 3, LP has the largest disclosed position value at $93.6M.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Section 32 Fund 3, LP's linked filing trail.
Disclosed position value
Top 5
Section 32 Fund 3, LP
$93.6M
DA32 Sponsor LLC
$44.65M
ARCH Venture Fund XI, L.P.
$6.5M
DEERFIELD MANAGEMENT COMPANY, L.P.
$6.5M
Keith Crandell
$6.5M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Section 32 Fund 3, LP |
3/4/5
Director, Director by Deputization, 10%+ Owner
|
—
class O/S missing
|
$93,600,000
9,360,000 shares
|
— | 05 Aug 2021 |
| DA32 Sponsor LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$44,650,000
4,465,000 shares
|
— | 05 Aug 2021 |
| ARCH Venture Fund XI, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$6,500,000
650,000 shares
|
— | 28 Jul 2023 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
3/4/5
Director, Director by Deputization, 10%+ Owner
|
—
class O/S missing
|
$6,500,000
650,000 shares
|
— | 28 Jul 2023 |
| Keith Crandell |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$6,500,000
650,000 shares
|
— | 28 Jul 2023 |
| Chris Wolfe |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
$1,250,000
125,000 shares
|
— | 05 Aug 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 06 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to DA32 Life Science Tech Acquisition Corp.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Section 32 Fund 3, LP
Net 12M change
$0
Latest report
28 Jul 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Section 32 Fund 3, LP | Director, Director by Deputization, 10%+ Owner | $93,600,000 | Mixed | 05 Aug 2021 | ||
| DA32 Sponsor LLC | 10%+ Owner | $44,650,000 | Mixed | 05 Aug 2021 | ||
| Keith Crandell | Director, 10%+ Owner | $6,500,000 | Mixed | 28 Jul 2023 | ||
| ARCH Venture Fund XI, L.P. | 10%+ Owner | $6,500,000 | Mixed | 28 Jul 2023 | ||
| DEERFIELD MANAGEMENT COMPANY, L.P. | Director, Director by Deputization, 10%+ Owner | $6,500,000 | Mixed | 28 Jul 2023 | ||
| Chris Wolfe | Chief Financial Officer | $1,250,000 | Mixed | 05 Aug 2021 | ||
| Nicolas H. Roelofs PhD | Director | Mixed | 27 Jul 2021 | |||
| Andrew ElBardissi | Director | Mixed | 27 Jul 2021 | |||
| Angela Lai | Director | Mixed | 27 Jul 2021 | |||
| Steven J. Kafka | Chief Executive Officer, Director | Mixed | 27 Jul 2021 | |||
| E. Kevin Hrusovsky | Director | Mixed | 27 Jul 2021 | |||
| Mara G. Aspinall | Director | Mixed | 27 Jul 2021 |
Recent insider transactions for DA32 Life Science Tech Acquisition Corp.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.